Influence of the pH Synthesis of Fe3O4 Magnetic Nanoparticles on Their Applicability for Magnetic Hyperthermia: An In Vitro Analysis
Nanotechnology, specifically magnetic nanoparticles (MNPs), is revolutionizing cancer treatment. Magnetic hyperthermia is a treatment that, using MNPs, can selectively kill cancer cells without causing damage to the surrounding tissues. <b>Background/Objectives</b>: This work aimed to analyze how the synthesis conditions, namely, how the pH of the reaction can influence the magnetic properties of Fe<sub>3</sub>O<sub>4</sub> nanoparticles for magnetic hyperthermia, using the hydrothermal synthesis. <b>Methods</b>: For the hydrothermal synthesis, FeCl<sub>3</sub>·6H<sub>2</sub>O and FeCl<sub>2</sub>·4H<sub>2</sub>O were mixed with different quantities of NaOH to adjust the pH. After obtaining a black precipitate, the samples were placed in an autoclave at 200 °C for 60 h, followed by a washing and drying phase. The obtained MNPs were analyzed using X-Ray Diffraction (XRD), Transmission Electron Microscopy, a Superconducting Quantum Interference Device, Specific Absorption Rate analysis, and cytotoxicity assays. <b>Results</b>: Different MNPs were analyzed (9.06 < pH < 12.75). The XRD results showed the presence of various iron oxide phases (magnetite, maghemite, and hematite), resulting from the oxidization of the iron phases present in the autoclave. In terms of the average particle size, it was verified that, by increasing the pH value, the size decreases (from 53.53 nm to 9.49 nm). Additionally, MNPs possess a superparamagnetic behaviour with high SAR values (above 69.3 W/g). <b>Conclusions</b>: It was found that the pH of the reaction can influence the size, morphology, magnetization, and thermal efficiency of the MNP. The MNP with the highest composition of Fe<sub>3</sub>O<sub>4</sub> was synthesized with a pH of 12.75, with a cubic morphology and a SAR value of 92.7 ± 3.2 W/g.
Authors
- M.P.F. Graça (ORCID: https://orcid.org/0000-0002-6858-9507)
- Eurico Pereira (ORCID: https://orcid.org/0000-0002-6532-2989)
- Laura C. J. Pereira (ORCID: https://orcid.org/0000-0002-8818-0039)
- S. Soreto Teixeira (ORCID: https://orcid.org/0000-0003-4084-5764)
- Ana Salomé Pires (ORCID: https://orcid.org/0000-0001-7994-4650)
- Maria Filomena Botelho (ORCID: https://orcid.org/0000-0001-7202-1650)
- Fernando Mendes (ORCID: https://orcid.org/0000-0002-5205-8939)
- Paula I. P. Soares (ORCID: https://orcid.org/0000-0002-4975-7480)
- Vital Cruvinel Ferreira-Filho (ORCID: https://orcid.org/0009-0002-1493-5950)
- Bárbara Costa (ORCID: https://orcid.org/0000-0001-7626-0210)
Institutions
- University of Lisbon (PT)
- Iscte – Instituto Universitário de Lisboa (PT)
- University of Aveiro (PT)
- University of Coimbra (PT)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2025-06-27
- DOI
- https://doi.org/10.3390/pharmaceutics17070844
- Citations
- 6
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 3.58
Funders
- Universidade de Coimbra
- Fundação para a Ciência e a Tecnologia